Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Neos Therapeutics, Inc. (Nasdaq - NEOS)

BALA CYNWYD, PA / ACCESSWIRE / December 10, 2020 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Neos Therapeutics, Inc. (NASDAQ:NEOS) ("NEOS" or the "Company") for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to be acquired by Aytu BioScience, Inc. (NASDAQ:AYTU) ("Aytu"). Under the terms of the agreement, MTS shareholders will receive only 0.1088 shares of Aytu for each share of NEOS they own, after taking into account the December 8, 2020 one-for-ten reverse split of Aytu's common stock. The transaction will result in NEOS stockholders owning only approximately 30% of the fully diluted common shares of Aytu.

The investigation concerns whether the NEOS Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Aytu is underpaying for the Company.

If you own shares of NEOS stock and wish to discuss the legal ramifications of the investigation or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC, who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, visit https://www.brodskysmith.com/cases/neos-therapeutics-inc-nasdaq-neos/, or call toll free 877-534-2590.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC



View source version on accesswire.com:
https://www.accesswire.com/620406/SHAREHOLDER-NOTICE-Brodsky-Smith-LLC-Announces-an-Investigation-of-Neos-Therapeutics-Inc-Nasdaq--NEOS



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today